Livzon Pharmaceutical Group Inc. provided earnings guidance for the first quarter ended March 31, 2017. For the period, the company expects net profit attributable to the shareholders of the company in range of approximately RMB 269.2309 million to RMB 287.6399 million. The company expects basic earnings per share in range of approximately RMB 0.64 to RMB 0.69. The company expects profit to be in a range of RMB 232.8571 million to RMB 251.7886 million.